GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2020-10-23 $16.53 $17.05 $16.18 $16.32 243 801
2020-10-22 $16.59 $17.15 $16.22 $16.49 356 081
2020-10-21 $16.29 $17.24 $15.88 $16.69 465 834
2020-10-20 $16.08 $16.48 $15.68 $16.28 302 097
2020-10-19 $16.61 $17.00 $16.15 $16.20 584 028
2020-10-16 $15.79 $15.98 $15.28 $15.76 500 712
2020-10-15 $16.04 $16.26 $15.16 $15.44 431 359
2020-10-14 $17.10 $17.31 $15.40 $16.33 717 871
2020-10-13 $16.92 $17.58 $16.56 $17.15 416 534
2020-10-12 $17.27 $17.72 $16.81 $16.89 330 594
2020-10-09 $17.25 $17.51 $16.87 $17.13 600 841
2020-10-08 $18.46 $18.72 $16.79 $17.01 543 006
2020-10-07 $18.16 $19.32 $17.62 $18.22 971 632
2020-10-06 $15.04 $18.79 $14.55 $18.16 2 427 804
2020-10-05 $15.46 $16.27 $14.52 $15.20 1 169 253
2020-10-02 $14.56 $15.43 $14.40 $14.99 860 010
2020-10-01 $14.85 $15.48 $14.60 $14.99 823 384
2020-09-30 $15.12 $15.63 $14.33 $14.83 1 494 881
2020-09-29 $15.30 $16.19 $14.22 $15.19 2 183 472
2020-09-28 $12.96 $15.65 $12.82 $14.98 3 596 079
2020-09-25 $12.00 $12.97 $11.88 $12.80 577 683
2020-09-24 $12.10 $12.45 $11.55 $12.09 521 381
2020-09-23 $12.39 $13.33 $12.09 $12.23 833 561
2020-09-22 $12.57 $12.79 $12.00 $12.45 360 481
2020-09-21 $12.85 $12.89 $12.33 $12.52 742 173
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT